Its All About SUPPLY
Feb05

Its All About SUPPLY

The Cannabis industry has enjoyed a very good run and it stands to get even better in the coming years. As legalization spreads to every state and acceptance of Cannabis as a Medicine becomes even more mainstream, economic forces that effect every industry and commodity will pose the industries first major challenge. Supply, demand and pricing will be increasing important factors in determining the health of the industry and the...

Read More
Cannabis-As-A-Medicine (CAAM) is Real and the Economic Impact is Significant
Jul19

Cannabis-As-A-Medicine (CAAM) is Real and the Economic Impact is Significant

A new study published in the journal called Health Affairs analyzed prescription drug usage in U.S. states where medical marijuana laws are in place. The study gathered Medicare data from 2010 – 2013 to see if patients were using cannabis to replace prescription drugs and the economic impact cannabis is having on Medicare. “In 2013 alone, when 17 states had legalized medical marijuana, Medicare saved over $165 million. A simple...

Read More
GW Pharmaceuticals Raising $252 Million is Watershed Moment for the Cannabis Industry
Jul14

GW Pharmaceuticals Raising $252 Million is Watershed Moment for the Cannabis Industry

Something new just happened in the cannabis industry. GW Pharmaceuticals raised $252 million, post-capital raise, GW Pharmaceuticals will have $514 million in cash on hand. This ~$250mil raise, by a ~$3bil UK pharma company that exclusively produces, processes, researches, develops drugs, and markets products derived from whole plant cannabis, real marijuana, is an industry first and is more than the total amount of capital invested...

Read More
Scotts Miracle-Gro Invests $120 Million For a 75% Stake in Gavita International
Jul07

Scotts Miracle-Gro Invests $120 Million For a 75% Stake in Gavita International

Today, Scott’s Miracle-Gro announced their 2nd large investment in the cannabis industry by investing $120 million for a 75% stake in Gavita International, “an Amsterdam-based lighting and hydroponics equipment outfit.” Back in April 2015, Scotts Miracle-Gro made its first foray into the cannabis industry by acquiring General Hydroponics, “a major international supplier of liquid nutrients used to grow food, flowers, and indoor...

Read More
Cantor Fitzgerald Initiates Coverage on GW Pharmaceuticals with a $181 Price Target
Jul05

Cantor Fitzgerald Initiates Coverage on GW Pharmaceuticals with a $181 Price Target

On June 3rd, Elemer Piros Ph.D., and analyst from Cantor Fitzgerald initiated coverage on GW Pharmaceuticals (GWPH) with a $181 price target. The title of the report is “If I Had Epilepsy…” and in 2nd sentence of the report he finishes that statement by saying “If I had epilepsy, I’d want Epidiolex.” That was the statement from a volunteer physician who has experience working with GW Pharmaceutical’s epilepsy drug Epidiolex. Epidiolex...

Read More
Arrow Electronics, a Fortune 500 Company, Enters into a Manufacturing & Credit Facility Agreement with MYDX
Jul05

Arrow Electronics, a Fortune 500 Company, Enters into a Manufacturing & Credit Facility Agreement with MYDX

“MyDx, Inc. (OTCQB:MYDX), producer of its patented MyDx™ (My Diagnostic) product line, the first battery operated, handheld chemical analyzer for consumers, today announced it has signed an agreement with Arrow Electronics to scale its supply chain and contract manufacturing capabilities for its MyDx product line.” Arrow Electronics (NYSE:ARW) is a global provider of products, services and solutions to industrial and commercial users...

Read More
New Frontier’s analysis and reporting on the Cannabis industry provides unparalleled insight into the key developments, trends and opportunities.